HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

TNFR2-deficient memory CD8 T cells provide superior protection against tumor cell growth.

Abstract
TNF receptor-2 (TNFR2) plays a critical role in promoting the activation and survival of naive T cells during the primary response. Interestingly, anti-CD3 plus IL-2 activated TNFR2(-/-) CD8 T cells are highly resistant to activation-induced cell death (AICD), which correlates with high expression levels of prosurvival molecules such as Bcl-2, survivin, and CD127 (IL-7Ralpha). We determined whether the resistance of activated TNFR2(-/-) CD8 T cells to AICD contributes to more effective protection against tumor cell growth. We found that during a primary tumor challenge, despite initial inferiority in controlling tumor cell growth, TNFR2(-/-) mice were able to more effectively control tumor burden over time compared with wild-type (WT) mice. Furthermore, vaccination of TNFR2(-/-) mice with recombinant Listeria monocytogenes that express OVA confers better protection against the growth of OVA-expressing E.G7 tumor cells relative to similarly vaccinated WT mice. The enhanced protection against tumor cell growth was not due to more effective activation of OVA-specific memory CD8 T cells in vaccinated TNFR2(-/-) mice. In vitro studies indicate that optimally activated OVA-specific TNFR2(-/-) CD8 T cells proliferated to the same extent and possess similar cytotoxicity against E.G7 tumor cells as WT CD8 T cells. However, relative to WT cells, activated OVA-specific TNFR2(-/-) CD8 T cells were highly resistant to AICD. Thus, the enhanced protection against E.G7 in TNFR2(-/-) mice is likely due to the recruitment and activation of OVA-specific memory TNFR2(-/-) CD8 T cells and their prolonged survival at the tumor site.
AuthorsEdward Y Kim, Soo-Jeet Teh, Jocelyn Yang, Michael T Chow, Hung-Sia Teh
JournalJournal of immunology (Baltimore, Md. : 1950) (J Immunol) Vol. 183 Issue 10 Pg. 6051-7 (Nov 15 2009) ISSN: 1550-6606 [Electronic] United States
PMID19841176 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Interleukin-2
  • OVA-8
  • Peptide Fragments
  • Receptors, Tumor Necrosis Factor, Type II
  • Ovalbumin
Topics
  • Animals
  • Apoptosis (immunology)
  • CD8-Positive T-Lymphocytes (immunology, metabolism)
  • Cell Line, Tumor
  • Immunologic Memory
  • Interleukin-2 (pharmacology)
  • Lymphocyte Activation (drug effects, immunology)
  • Mice
  • Mice, Knockout
  • Mice, Mutant Strains
  • Mice, Transgenic
  • Neoplasms (immunology, metabolism)
  • Ovalbumin (immunology)
  • Peptide Fragments (immunology)
  • Receptors, Tumor Necrosis Factor, Type II (genetics, immunology, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: